Stallergenes Greer plc Notice of Results
16 August 2018 - 4:00PM
UK Regulatory
TIDM0RB9
Stallergenes Greer to Report First Half Financial Results on 29
August 2018
Stallergenes Greer (Paris:STAGR), a biopharmaceutical company
specializing in treatments for respiratory allergies, today
announced it will report financial results for the first half of
its 2018 fiscal year after the market closes on 29 August 2018. The
Company's management will host a live audio webcast of its earnings
conference call the following day, 30 August 2018, at 10:30 am
London / 11:30am Paris / 5:30 am Boston to discuss the results.
Members of the financial community may access the conference
through the dial-in information provided on the company's website
at http://stallergenesgreer.com/financial-calendar-events. The live
audio webcast will be accessible to the general public via the
following link: https://edge.media-server.com/m6/go/STAGR_18HY.
Participants are asked to connect at least 15 minutes prior to the
conference call to register, download and install any necessary
audio software.
ABOUT STALLERGENES GREER PLC
Headquartered in London (UK), Stallergenes Greer plc is a global
healthcare company specializing in the diagnosis and treatment of
allergies through the development and commercialization of allergy
immunotherapy products and services. Stallergenes Greer plc is the
parent company of GREER Laboratories, Inc. (whose registered office
is in the US) and Stallergenes SAS (whose registered office is in
France).
TRADING INFORMATIONName: Stallergenes GreerISIN: GB00BZ21RF93 1
- Ticker: STAGRICB Classification: 4577LEI:
213800CYVZA7GJQEME86Market: Euronext Paris regulated market
Additional information is available at
http://www.stallergenesgreer.com.
This document (including information incorporated by reference
in this document), oral statements made and other information
published by the Company contain statements that are or may be
forward-looking with respect to the financial condition and/or
results of operations and businesses of the Company. These
statements can be identified by the use of forward-looking
terminology such as "believe," "expects," "project," "estimated,"
"forecast," "should," "plan," "may" or the negative of any of
these, or other variations thereof, or comparable terminology
indicating expectations or beliefs concerning future events. These
forward-looking statements include risk and uncertainty because
they relate to events and depend on circumstances that will occur
in the future. Without being exhaustive, such factors include
economic situations and business conditions, including legal and
product evaluation issues, fluctuations in currencies and demand,
and changes in competitive factors. These and other factors are
more fully described in the Company's 2017 annual report published
on 16 April 2018 on the Company's website
www.stallergenesgreer.com. Actual results may differ from those set
forth in the forward-looking statements, due to various factors.
Save as required by applicable law, neither the Company nor any
other person assumes any obligation to update these forward-looking
statements or to notify any person of any such update.
Stallergenes GreerCommunications and Investor RelationsNatacha
GassenbachTel: +1 (617) 682 2626Email:
natacha.gassenbach@stallergenesgreer.comorCaitlin StefanikTel: +1
(857) 331 4117Email: caitlin.stefanik@stallergenesgreer.comorMedia
Relations AgencyHavas Paris (Europe)Samuel Rousseau+33 6 77 88 32
43E-mail : samuel.rousseau@havas.comorInvestor Relations AgencyFTI
ConsultingArnaud de CheffontainesTel: +33 1 47 03 68 10Email:
stalleregenesgreer@fticonsulting.com
View source version on businesswire.com:
https://www.businesswire.com/news/home/20180815005056/en/
This information is provided by Business Wire
(END) Dow Jones Newswires
August 16, 2018 02:00 ET (06:00 GMT)
Stallergenes Greer (LSE:0RB9)
Historical Stock Chart
From Apr 2024 to May 2024
Stallergenes Greer (LSE:0RB9)
Historical Stock Chart
From May 2023 to May 2024